Tianjin Lisheng Pharmaceutical FY Total Revenue From Operations Rmb1.62 BLn
28/02/2020 09:00
Feb 28 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN LISHENG PHARMACEUTICAL FY TOTAL REVENUE FROM
OPERATIONS
RMB1.62 BILLION VERSUS RMB1.50 BILLION
* TIANJIN LISHENG PHARMACEUTICAL FY NET PROFIT ATTRIBUTABLE
RMB187.0 MILLION VERSUS RMB185 MILLION
Source text for Eikon: ID:nHKS6HjmY3
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln